ACM
PALI icon

Altium Capital Management’s Palisade Bio PALI Stock Holding History

Altium Capital Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,524
Closed -$559K – 122
2022
Q3 		$559K Buy
+7,524
New +$1.59M 0.2% 93
2022
Q1 		– Sell
-445
Closed -$434K – 148
2021
Q4 		$434K Buy
+445
New +$778K 0.12% 105
2021
Q3 		– Sell
-2,433
Closed -$7.43M – 147
2021
Q2 		$7.43M Buy
+2,433
New +$11M 1.72% 9

Other funds holding PALI

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Altium Capital Management's PALI Position: Q4 2022 in Review

Altium Capital Management sold out of Palisade Bio (PALI) in Q4 2022, closing a stake of 7,524 shares — an estimated $559K sold.

Altium Capital Management first reported a position in PALI in Q2 2021 and held it in 3 quarters. The position peaked at $7.43M in Q2 2021. 11 funds tracked by Wall St. Rank hold PALI as of Q4 2022.

  • Altium Capital Management reported no remaining Palisade Bio position as of Q4 2022 after selling out during the quarter.
  • Altium Capital Management sold 7,524 Palisade Bio shares in Q4 2022, an estimated $559K.
  • Altium Capital Management first reported a position in Palisade Bio in Q2 2021 and held it in 3 quarters.
  • Altium Capital Management's Palisade Bio position peaked at $7.43M in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2022.

Based on Altium Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.